|
1
|
Legué LM, Creemers GJ, de Hingh IHJT,
Lemmens VEPP and Huysentruyt CJ: Pathologyand its clinical
relevance of mucinous appendiceal neoplasms and pseudomyxoma
peritonei. Clin Colorectal Cancer. 18:1–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carr NJ, Bibeau F, Bradley RF, Dartigues
P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J,
et al: The histopathological classification, diagnosis and
differential diagnosis of mucinous appendiceal neoplasms,
appendiceal adenocarcinomas and pseudomyxoma peritonei.
Histopathology. 71:847–858. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shaib WL, Assi R, Shamseddine A, Alese OB,
Staley C III, Memis B, Adsay V, Bekaii-Saab T and El-Rayes BF:
Appendiceal mucinous neoplasms: Diagnosis and management.
Oncologist. 22:1107–1116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perivoliotis K, Christodoulidis G, Samara
AA, Sgantzou IK, Floros T, Volakakis G, Karasavvidou F and Tepetes
K: Low-grade appendiceal mucinous neoplasm (LAMN) primarily
diagnosed as an ovarian mucinous tumor. Case Rep Surg.
22:55237362021.PubMed/NCBI
|
|
5
|
Arshi J, Peter AD, Liang Y and Hao Y:
Confined low grade appendiceal mucinous neoplasm with coexisting
distant metastasis. In Vivo. 38:295–298. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guzman GA, Montealegre I and Obando AM:
Incidental diagnosis of a low-grade mucinous appendicular neoplasm:
A case report. Int J Surg Case Rep 105998. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu X-R, Mao J, Tang W, Meng X-Y, Tian Y
and Du Z-L: Low-grade appendiceal mucinous neoplasms confined to
the appendix: Clinical manifestations and CT findings. J Invest
Med. 68:75–81. 2020. View Article : Google Scholar
|
|
8
|
Schmoeckel E, Kirchner T and Mayr D: SATB2
is a supportive marker for the differentiation of a primary
mucinous tumor of the ovary and an ovarian metastasis of a
low-grade appendiceal mucinous neoplasm (LAMN): A series of seven
cases. Pathol Res Pract. 214:426–430. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aldaoud N, Erashdi M, Alkhatib S, Abdo N,
Al-Mohtaseb A and Graboski-Bauer A: The utility of PAX8 and SATB2
immunohistochemical stains in distinguishing ovarian mucinous
neoplasms from colonic and appendiceal mucinous neoplasm. BMC Res
Notes. 12:7702019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Borges AL, Reis-de-Carvalho C, Chorao M,
Pereira H and Djokovic D: Low-grade mucinous appendiceal neoplasm
mimicking an ovarian lesion: A case report and review of
literature. World J Clin Cases. 9:2334–2343. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang W, Nie P, Liu X and Peng J:
Comparative effectiveness of prophylactic hyperthermic
intraperitoneal chemotherapy (HIPEC) for resected low-grade
appendiceal ucinous neoplasm (LAMN). A protocol for systematic
review and network meta-analysis. Medicine (Baltimore).
99:e220712020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guaglio M, Sinukumar S, Kusamura S,
Milione M, Pietrantonio F, Battaglia L, Guadagni S, Baratti D and
Deraco M: Clinical surveillance after macroscopically complete
surgery forlow-grade appendiceal mucinous neoplasms (LAMN) with or
without limited peritoneal spread: Long-term results in a
prospective series. Ann Surg Oncol. 25:878–884. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Istl AC, Gage MM, Esquivel J, Ahuja N,
Greer JB and Johnston FM: Management of low-grade appendiceal
mucinous neoplasms (LAMN): An international survey of surgeons
performing CRS and HIPEC. Ann Surg Oncol. 28:3831–3837. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watanabe H, Miyasaki Y, Watanabe K,
Sakamoto I, Nakagomi H, Takano A, Ikegame K, Yamamoto A, Nakada H,
Yosutome M, et al: Pseudomyxoma peritonei due to low-grade
appendiceal mucinous neoplasm with symptoms of inguinal hernia and
uterine prolapse: A case report and review of the literature. Int
Cancer Conf J. 6:158–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ceelen W, Man MD, Willaert W, H van
Ramshorst G, Geboes K and Hoorens A: Incidentally found mucinous
epithelial tumors of the appendix with or without pseudomyxoma
peritonei: Diagnostic and therapeutic algorithms based on current
evidence. Acta Chir Belg. 121:225–234. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hegg KS, Mack LA, Bouchard-Fortier A,
Temple WJ and Gui X: Macroscopic and microscopic characteristics of
low grade appendiceal mucinous neoplasms (LAMN) on appendectomy
specimens and correlations with pseudomyxoma peritonei development
risk. Ann Diagn Pathol. 48:1516062020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dundr P, Singh N, Nozickova B, Nemejcova
K, Bartu M and Struzinska I: Primary mucinous ovarian tumors vs.
ovarian metastases from gastrointestinal tract, pancreas and
biliary tree: A review of current problematics. Diagn Pathol.
16:202021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mills AM and Shanes ED: Mucinous ovarian
tumors. Surg Pathol Clin. 12:565–585. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kubecek O, Laco J, Spacek J, Petera J,
Kopecky J, Kubeckova A and Filip S: The pathogenesis, diagnosis,
and management of metastatic tumors to the ovary: A comprehensive
review. Clin Exp Metastasis. 34:295–307. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vang R, Gown AM, Wu L-S-F, Barry TS,
Wheeler DT, Yemelyanova A, Seidman JD and Ronnett BM:
Immunohistochemical expression of CDX2 in primary ovarian mucinous
tumors and metastatic mucinous carcinomas involving the ovary:
Comparison with CK20 and correlation with coordinate expression of
CK7. Mod Pathol. 19:1421–1428. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Rock JB, Roth R, Lehman A, Marsh WL,
Suarez A and Frankel WL: Dual stain with SATB2 and CK20/Villin is
useful to distinguish colorectal carcinomas from other tumors. Am J
Clin Pathol. 149:241–246. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meagher NS, Wang L, Rambau PF, Intermaggio
MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K,
Steed H, et al: A combination of the immunohistochemical markers
CK7 and SATB2 is highly sensitive and specific for distinguishing
primary ovarian mucinous tumors from colorectal and appendiceal
metastases. Mod Pathol. 32:1834–1846. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ilieva N, Tashkova D, Staykov D, Serteva
D, Feodorova Y, Mehterov N, Mollova A and Bachurska S:
Immunohistochemical expression of CK20, CK7, and CDX2 in colorectal
carcinoma in correlation with pathomorphological characteristics.
Folia Med (Plovdiv). 64:214–220. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bassiouny D, Ismiil N, Dube V, Han G,
Cesari M, Lu FI, Slodkowska E, Parra-Herran C, Chiu HF, Naeim M, et
al: Comprehensive clinicopathologic and updated immunohistochemical
characterization of primary ovarian mucinous carcinoma. Int J Surg
Pathol. 26:306–317. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Roth R, Rock JB, Lehman A, Marsh WL,
Suarez A and Frankel WL: Dual immunostain with SATB2 and CK20
differentiates appendiceal mucinous neoplasms from ovarian mucinous
neoplasms. Am J Clin Pathol. 147:484–491. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Genestie C, Auguste A, Al Battal M,
Scoazec JY, Gouy S, Lacroix L, Morice P, Pautier P, Leary A and
Devouassoux-Shisheboran M: Histological classification of mucinous
ovarian tumors: Inter-observer reproducibility, clinical relevance,
and role of genetic biomarkers. Virchows Arch. 478:885–891. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yanai Y, Saito T, Hayashi T, Akazawa Y,
Yatagai N, Tsuyama S, Tomita S, Hirai S, Ogura K, Matsumoto T, et
al: Molecular and clinicopathological features of appendiceal
mucinous neoplasms. Virchows Arch. 478:413–426. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gorringe KL, Cheasley D, Wakefield MJ,
Ryland GL, Allan PE, Alsop K, Amarasinghe KC, Ananda S, Bowtell
DDL, Christie M, et al: Therapeutic options for mucinous ovarian
carcinoma. Gynecol Oncol. 156:552–560. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Babaier A and Ghatage P: Mucinous cancer
of the ovary: Overview and current status. Diagnostics (Basel).
10:522020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Misdraji J: Mucinous epithelial neoplasms
of the appendix and pseudomyxoma peritonei. Mod Pathol. 28
(Suppl):S67–S79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ciarrocchi A, Rindi G and Pietroletti R:
Diagnosis and treatment of primary tumors of the appendix: A
critical review. J Gastrointest Cancer. 52:471–475. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Govaerts K, Lurvink RJ, De Hingh IHJT, Van
der Speeten K, Villeneuve L, Kusamura S, Kepenekian V, Deraco M,
Glehen O and Moran BJ: PSOGI: Appendiceal tumours and pseudomyxoma
peritonei: Literature review with PSOGI/EURACAN clinical
practiceguidelines for diagnosis and treatment. Eur J Surg Oncol.
2021.47:11–35. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Auer RC, Sivajohanathan D, Biagi J, Conner
J, Kennedy E and May T: Indications for hyperthermic
intraperitoneal chemotherapy with cytoreductive surgery: A
systematic review. Eur J Cancer. 127:76–95. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Zhou J, Dong M and Yang L:
Management and prognosis of low-grade appendiceal mucinous
neoplasms: A clinicopathologic analysis of 50 cases. Eur J Surg
Oncol. 44:1640–1645. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen I, Liu X, Kovar-Peltz S, Conrad SJ,
Chen HH and Liao X: Clinicopathological spectrums and prognosis of
primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and
low-grade appendiceal mucinous neoplasms. Pathology. 55:375–382.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kohler F, Reese L, Hendricks A, Kastner C,
Muller S, Lock JF, German C-T and Wiegering A: Low-grade mucinous
neoplasms (LAMN) of the appendix in Germany between2011 and 2018: A
nationwide analysis based on data provided by the German Center for
Cancer Registry Data (ZfKD) at the Robert Koch Institute (RKI).
Langenbecks Arch Surg. 407:3615–3622. 2022. View Article : Google Scholar : PubMed/NCBI
|
